$3.27 Billion is the total value of PFM Health Sciences, LP's 86 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 67.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| XLV | New | SELECT SECTOR SPDR TRput | $185,033,000 | – | 1,585,000 | +100.0% | 5.65% | – |
| OM | Buy | OUTSET MED INC | $163,861,000 | +8.8% | 3,012,709 | +3.5% | 5.00% | -5.5% |
| ALXN | Buy | ALEXION PHARMACEUTICALS INC | $162,028,000 | +5.7% | 1,059,631 | +8.0% | 4.95% | -8.3% |
| HZNP | Buy | HORIZON THERAPEUTICS PUB L | $146,100,000 | +50.3% | 1,587,348 | +19.5% | 4.46% | +30.5% |
| NBIX | New | NEUROCRINE BIOSCIENCES INC | $102,648,000 | – | 1,055,510 | +100.0% | 3.14% | – |
| ABBV | ABBVIE INC | $100,301,000 | +1.0% | 926,823 | 0.0% | 3.06% | -12.3% | |
| RCUS | Buy | ARCUS BIOSCIENCES INC | $98,231,000 | +12.2% | 3,498,260 | +3.7% | 3.00% | -2.6% |
| LLY | Buy | LILLY ELI & CO | $98,166,000 | +65.8% | 525,455 | +49.9% | 3.00% | +43.9% |
| MYGN | New | MYRIAD GENETICS INC | $82,782,000 | – | 2,718,623 | +100.0% | 2.53% | – |
| HCA | Buy | HCA HEALTHCARE INC | $73,548,000 | +42.7% | 390,507 | +24.6% | 2.25% | +23.8% |
| GILD | Buy | GILEAD SCIENCES INC | $69,481,000 | +26.6% | 1,075,063 | +14.2% | 2.12% | +9.9% |
| MCK | Buy | MCKESSON CORP | $69,479,000 | +29.3% | 356,231 | +15.3% | 2.12% | +12.3% |
| IQV | Sell | IQVIA HLDGS INC | $69,128,000 | +3.4% | 357,916 | -4.1% | 2.11% | -10.3% |
| UHS | Buy | UNIVERSAL HLTH SVCS INCcl b | $64,961,000 | +6.9% | 487,000 | +10.2% | 1.98% | -7.2% |
| AVTR | Buy | AVANTOR INC | $64,504,000 | +10.5% | 2,229,657 | +7.5% | 1.97% | -4.1% |
| NVRO | Buy | NEVRO CORP | $62,060,000 | +14.9% | 444,877 | +42.6% | 1.90% | -0.3% |
| IBB | New | ISHARES TRput | $61,504,000 | – | 408,500 | +100.0% | 1.88% | – |
| ICUI | Buy | ICU MED INC | $59,713,000 | +3.9% | 290,661 | +8.5% | 1.82% | -9.7% |
| HUM | Buy | HUMANA INC | $59,704,000 | +87.2% | 142,406 | +83.2% | 1.82% | +62.5% |
| UNH | Buy | UNITEDHEALTH GROUP INC | $54,060,000 | +51.0% | 145,295 | +42.3% | 1.65% | +31.0% |
| MRTX | Buy | MIRATI THERAPEUTICS INC | $53,065,000 | +15.6% | 309,780 | +48.2% | 1.62% | +0.4% |
| Sell | AERIE PHARMACEUTICALS INCnote 1.500%10/0 | $49,991,000 | +4.2% | 48,150,000 | -7.1% | 1.53% | -9.5% | |
| XBI | New | SPDR SER TRcall | $47,478,000 | – | 350,000 | +100.0% | 1.45% | – |
| Buy | BIOMARIN PHARMACEUTICAL INCnote 0.599% 8/0 | $47,356,000 | +9.6% | 45,910,000 | +13.9% | 1.45% | -4.9% | |
| EW | Buy | EDWARDS LIFESCIENCES CORP | $42,908,000 | -3.6% | 513,005 | +5.2% | 1.31% | -16.3% |
| MYOV | Buy | MYOVANT SCIENCES LTD | $42,290,000 | +46.4% | 2,054,928 | +96.4% | 1.29% | +26.9% |
| PPD | Buy | PPD INC | $41,491,000 | +63.2% | 1,096,492 | +47.6% | 1.27% | +41.7% |
| AZN | Sell | ASTRAZENECA PLCsponsored adr | $40,293,000 | -26.4% | 810,400 | -26.0% | 1.23% | -36.1% |
| DHR | Buy | DANAHER CORPORATION | $39,544,000 | +3.9% | 175,690 | +2.6% | 1.21% | -9.7% |
| BAX | New | BAXTER INTL INC | $38,668,000 | – | 458,476 | +100.0% | 1.18% | – |
| AERI | Sell | AERIE PHARMACEUTICALS INC | $36,950,000 | +22.8% | 2,067,684 | -7.2% | 1.13% | +6.5% |
| NVAX | Sell | NOVAVAX INC | $36,397,000 | +51.2% | 200,745 | -7.0% | 1.11% | +31.3% |
| CYTK | Buy | CYTOKINETICS INC | $35,736,000 | +77.1% | 1,536,373 | +58.2% | 1.09% | +53.7% |
| CNC | Buy | CENTENE CORP DEL | $34,107,000 | +73.0% | 533,667 | +62.5% | 1.04% | +50.1% |
| HRTX | Buy | HERON THERAPEUTICS INC | $34,018,000 | -20.1% | 2,098,578 | +4.3% | 1.04% | -30.6% |
| ACAD | Buy | ACADIA PHARMACEUTICALS INC | $33,595,000 | -50.1% | 1,302,129 | +3.4% | 1.03% | -56.7% |
| JNCE | New | JOUNCE THERAPEUTICS INC | $33,509,000 | – | 3,262,833 | +100.0% | 1.02% | – |
| JWS | Buy | JAWS ACQUISITION CORP | $33,477,000 | +49.5% | 2,526,594 | +51.3% | 1.02% | +29.7% |
| SNDX | New | SYNDAX PHARMACEUTICALS INC | $33,187,000 | – | 1,484,227 | +100.0% | 1.01% | – |
| WAT | Buy | WATERS CORP | $32,137,000 | +37.5% | 113,089 | +19.7% | 0.98% | +19.3% |
| DXCM | New | DEXCOM INCcall | $31,339,000 | – | 87,200 | +100.0% | 0.96% | – |
| GH | Sell | GUARDANT HEALTH INC | $31,193,000 | +6.2% | 204,344 | -10.3% | 0.95% | -7.7% |
| ARKK | New | ARK ETF TRput | $31,031,000 | – | 258,700 | +100.0% | 0.95% | – |
| PODD | New | INSULET CORP | $30,888,000 | – | 118,382 | +100.0% | 0.94% | – |
| BFLY | New | BUTTERFLY NETWORK INC | $30,770,000 | – | 1,828,311 | +100.0% | 0.94% | – |
| DVAX | Buy | DYNAVAX TECHNOLOGIES CORP | $29,399,000 | +124.9% | 2,990,770 | +1.8% | 0.90% | +95.2% |
| THC | Sell | TENET HEALTHCARE CORP | $29,299,000 | -25.6% | 563,444 | -42.9% | 0.90% | -35.4% |
| BIIB | Sell | BIOGEN INC | $28,544,000 | +1.7% | 102,034 | -11.0% | 0.87% | -11.7% |
| NTLA | New | INTELLIA THERAPEUTICS INC | $22,801,000 | – | 284,101 | +100.0% | 0.70% | – |
| New | IONIS PHARMACEUTICALS INCnote 0.125%12/1 | $22,099,000 | – | 23,000,000 | +100.0% | 0.68% | – | |
| KRTX | New | KARUNA THERAPEUTICS INC | $21,503,000 | – | 178,846 | +100.0% | 0.66% | – |
| ALLO | New | ALLOGENE THERAPEUTICS INC | $20,840,000 | – | 590,378 | +100.0% | 0.64% | – |
| DXCM | New | DEXCOM INC | $20,285,000 | – | 56,442 | +100.0% | 0.62% | – |
| PEN | Sell | PENUMBRA INC | $20,118,000 | -42.4% | 74,351 | -62.8% | 0.61% | -50.0% |
| MOH | Sell | MOLINA HEALTHCARE INC | $16,384,000 | -24.4% | 70,088 | -31.2% | 0.50% | -34.4% |
| NVAX | Sell | NOVAVAX INCcall | $14,686,000 | -12.2% | 81,000 | -46.0% | 0.45% | -23.8% |
| ICUI | New | ICU MED INCcall | $14,134,000 | – | 68,800 | +100.0% | 0.43% | – |
| ADAP | Sell | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $13,282,000 | -8.6% | 2,501,303 | -7.2% | 0.41% | -20.5% |
| ZLAB | Sell | ZAI LAB LTDadr | $13,260,000 | -8.5% | 99,375 | -7.2% | 0.40% | -20.6% |
| ICLR | Sell | ICON PLC | $12,934,000 | -45.3% | 65,863 | -45.7% | 0.40% | -52.5% |
| INNV | New | INNOVAGE HLDG CORP | $11,082,000 | – | 429,699 | +100.0% | 0.34% | – |
| CNST | CONSTELLATION PHARMCETICLS I | $10,985,000 | -18.8% | 469,664 | 0.0% | 0.34% | -29.6% | |
| VRTX | New | VERTEX PHARMACEUTICALS INC | $10,076,000 | – | 46,889 | +100.0% | 0.31% | – |
| CERN | New | CERNER CORP | $10,032,000 | – | 139,569 | +100.0% | 0.31% | – |
| FSII | New | FS DEVELOPMENT CORP II | $9,960,000 | – | 1,000,000 | +100.0% | 0.30% | – |
| MDGL | New | MADRIGAL PHARMACEUTICALS INC | $9,654,000 | – | 82,534 | +100.0% | 0.30% | – |
| STTK | Sell | SHATTUCK LABS INC. | $9,191,000 | -43.3% | 326,813 | -15.5% | 0.28% | -50.7% |
| ALLO | New | ALLOGENE THERAPEUTICS INCcall | $8,684,000 | – | 246,000 | +100.0% | 0.26% | – |
| ATHA | ATHIRA PHARMA INC | $8,652,000 | -46.3% | 470,227 | 0.0% | 0.26% | -53.4% | |
| SBTX | SILVERBACK THERAPEUTICS INC | $8,213,000 | -5.8% | 188,243 | 0.0% | 0.25% | -18.2% | |
| KNTE | Sell | KINNATE BIOPHARMA INC | $8,235,000 | -39.5% | 264,293 | -22.7% | 0.25% | -47.5% |
| SPRB | Sell | SPRUCE BIOSCIENCES INC | $8,128,000 | -36.8% | 489,631 | -7.5% | 0.25% | -45.3% |
| ITOS | New | ITEOS THERAPEUTICS INC | $7,937,000 | – | 232,216 | +100.0% | 0.24% | – |
| TERN | New | TERNS PHARMACEUTICALS INC | $7,244,000 | – | 329,274 | +100.0% | 0.22% | – |
| CERT | Buy | CERTARA INC | $7,048,000 | -8.3% | 258,161 | +13.2% | 0.22% | -20.4% |
| Sell | NOVAVAX INCnote 3.750% 2/0 | $6,998,000 | -83.7% | 4,250,000 | -87.5% | 0.21% | -85.8% | |
| ONEM | New | 1LIFE HEALTHCARE INC | $6,710,000 | – | 171,689 | +100.0% | 0.20% | – |
| LUNG | Sell | PULMONX CORP | $6,247,000 | -69.2% | 136,576 | -54.9% | 0.19% | -73.2% |
| HRTX | New | HERON THERAPEUTICS INCcall | $5,254,000 | – | 324,100 | +100.0% | 0.16% | – |
| DVAX | New | DYNAVAX TECHNOLOGIES CORPcall | $4,915,000 | – | 500,000 | +100.0% | 0.15% | – |
| BLSA | Sell | BCLS ACQUISITION CORP | $4,906,000 | -11.0% | 464,103 | -7.2% | 0.15% | -22.7% |
| JYAC | Sell | JIYA ACQUISITION CORP | $4,567,000 | -11.3% | 464,103 | -7.2% | 0.14% | -23.2% |
| FLDM | Sell | FLUIDIGM CORP DEL | $4,432,000 | -30.1% | 980,505 | -7.2% | 0.14% | -39.5% |
| OSH | Sell | OAK STR HEALTH INC | $3,650,000 | -17.6% | 67,250 | -7.2% | 0.11% | -28.8% |
| NEVRO CORPnote 2.750% 4/0 | $3,032,000 | -17.3% | 2,000,000 | 0.0% | 0.09% | -27.9% | ||
| ALNA | ALLENA PHARMACEUTICALS | $395,000 | +8.5% | 284,285 | 0.0% | 0.01% | -7.7% | |
| Exit | ACORDA THERAPEUTICS INCnote 1.750% 6/1 | $0 | – | -2,000,000 | -100.0% | -0.04% | – | |
| EDIT | Exit | EDITAS MEDICINE INC | $0 | – | -29,900 | -100.0% | -0.07% | – |
| AMWL | Exit | AMERICAN WELL CORPcl a | $0 | – | -130,000 | -100.0% | -0.12% | – |
| RCUS | Exit | ARCUS BIOSCIENCES INCcall | $0 | – | -237,300 | -100.0% | -0.22% | – |
| CRSP | Exit | CRISPR THERAPEUTICS AGput | $0 | – | -41,000 | -100.0% | -0.22% | – |
| RVMD | Exit | REVOLUTION MEDICINES INC | $0 | – | -209,116 | -100.0% | -0.29% | – |
| PACB | Exit | PACIFIC BIOSCIENCES CALIF INput | $0 | – | -320,000 | -100.0% | -0.29% | – |
| Exit | TRILLIUM THERAPEUTICS INC | $0 | – | -599,111 | -100.0% | -0.31% | – | |
| MRTX | Exit | MIRATI THERAPEUTICS INCcall | $0 | – | -44,300 | -100.0% | -0.34% | – |
| MYOV | Exit | MYOVANT SCIENCES LTDcall | $0 | – | -411,500 | -100.0% | -0.40% | – |
| ACAD | Exit | ACADIA PHARMACEUTICALS INCcall | $0 | – | -270,000 | -100.0% | -0.51% | – |
| IONS | Exit | IONIS PHARMACEUTICALS INC | $0 | – | -263,412 | -100.0% | -0.52% | – |
| HZNP | Exit | HORIZON THERAPEUTICS PUB Lcall | $0 | – | -217,900 | -100.0% | -0.56% | – |
| IOVA | Exit | IOVANCE BIOTHERAPEUTICS INCput | $0 | – | -500,000 | -100.0% | -0.82% | – |
| TCRR | Exit | TCR2 THERAPEUTICS INC | $0 | – | -775,794 | -100.0% | -0.84% | – |
| PFE | Exit | PFIZER INC | $0 | – | -685,125 | -100.0% | -0.89% | – |
| LH | Exit | LABORATORY CORP AMER HLDGS | $0 | – | -128,100 | -100.0% | -0.92% | – |
| HSIC | Exit | HENRY SCHEIN INC | $0 | – | -395,161 | -100.0% | -0.93% | – |
| BMRN | Exit | BIOMARIN PHARMACEUTICAL INC | $0 | – | -314,499 | -100.0% | -0.97% | – |
| BMY | Exit | BRISTOL-MYERS SQUIBB CO | $0 | – | -451,275 | -100.0% | -0.98% | – |
| BMRN | Exit | BIOMARIN PHARMACEUTICAL INCcall | $0 | – | -371,700 | -100.0% | -1.15% | – |
| XLF | Exit | SELECT SECTOR SPDR TRcall | $0 | – | -1,188,100 | -100.0% | -1.23% | – |
| BIIB | Exit | BIOGEN INCcall | $0 | – | -160,000 | -100.0% | -1.38% | – |
| IRTC | Exit | IRHYTHM TECHNOLOGIES INC | $0 | – | -171,028 | -100.0% | -1.43% | – |
| ALXN | Exit | ALEXION PHARMACEUTICALS INCcall | $0 | – | -300,000 | -100.0% | -1.65% | – |
| ANTM | Exit | ANTHEM INC | $0 | – | -164,238 | -100.0% | -1.86% | – |
| MRNA | Exit | MODERNA INCput | $0 | – | -540,000 | -100.0% | -1.98% | – |
| ARKG | Exit | ARK ETF TRput | $0 | – | -900,000 | -100.0% | -2.95% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-05-17
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MOLINA HEALTHCARE INC | 41 | Q3 2023 | 2.2% |
| HCA HOLDINGS INC | 38 | Q3 2023 | 5.2% |
| HUMANA INC | 37 | Q3 2023 | 3.8% |
| EDWARDS LIFESCIENCES CORP | 36 | Q3 2023 | 3.3% |
| UNITEDHEALTH GROUP INC | 33 | Q3 2023 | 4.8% |
| PENUMBRA INC | 33 | Q3 2023 | 4.8% |
| AERIE PHARMACEUTICALS INC | 28 | Q2 2022 | 3.7% |
| TENET HEALTHCARE CORP | 27 | Q3 2023 | 2.3% |
| ELEVANCE HEALTH INC | 26 | Q3 2023 | 4.2% |
| ICON PLC | 26 | Q3 2023 | 2.5% |
View PFM Health Sciences, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Adaptimmune Therapeutics PLC | February 14, 2023 | ? | ? |
| Arcus Biosciences, Inc. | February 14, 2023 | ? | ? |
| Axsome Therapeutics, Inc. | February 14, 2023 | ? | ? |
| Erasca, Inc. | February 14, 2023 | ? | ? |
| Generation Bio Co. | February 14, 2023 | ? | ? |
| IO Biotech, Inc. | February 14, 2023 | ? | ? |
| Jounce Therapeutics, Inc. | February 14, 2023 | ? | ? |
| Outset Medical, Inc. | February 14, 2023 | ? | ? |
| uniQure N.V. | February 14, 2023 | ? | ? |
| AERIE PHARMACEUTICALS INC | February 14, 2022 | ? | ? |
View PFM Health Sciences, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G | 2023-04-21 |
View PFM Health Sciences, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.